A first example is Myasthenia gravis (MG), in which autoantibodies against nicotinic acetylcholine receptor and muscle-specific tyrosin kinase inhibit the signal transduction at the neuromuscular junction, and additionally lead to an immune-mediated reduction of the receptor [2]. This evidence concerns the gene EIF3K and myasthenia gravis.